DK0935652T3 - Keratinocyt vækstfaktor-2 produkter - Google Patents

Keratinocyt vækstfaktor-2 produkter

Info

Publication number
DK0935652T3
DK0935652T3 DK97910119T DK97910119T DK0935652T3 DK 0935652 T3 DK0935652 T3 DK 0935652T3 DK 97910119 T DK97910119 T DK 97910119T DK 97910119 T DK97910119 T DK 97910119T DK 0935652 T3 DK0935652 T3 DK 0935652T3
Authority
DK
Denmark
Prior art keywords
growth factor
keratinocyte growth
products
variants
chemical derivatives
Prior art date
Application number
DK97910119T
Other languages
English (en)
Inventor
Linda Owens Narhi
Timothy D Osslund
Original Assignee
Amgen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amgen Inc filed Critical Amgen Inc
Application granted granted Critical
Publication of DK0935652T3 publication Critical patent/DK0935652T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/50—Fibroblast growth factor [FGF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • Pulmonology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK97910119T 1996-10-15 1997-10-15 Keratinocyt vækstfaktor-2 produkter DK0935652T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US2849396P 1996-10-15 1996-10-15
US3278196P 1996-12-06 1996-12-06
US3304696P 1996-12-11 1996-12-11

Publications (1)

Publication Number Publication Date
DK0935652T3 true DK0935652T3 (da) 2004-07-26

Family

ID=27363281

Family Applications (1)

Application Number Title Priority Date Filing Date
DK97910119T DK0935652T3 (da) 1996-10-15 1997-10-15 Keratinocyt vækstfaktor-2 produkter

Country Status (11)

Country Link
EP (1) EP0935652B1 (da)
JP (2) JP2001506975A (da)
AT (1) ATE263239T1 (da)
AU (1) AU727678C (da)
CA (1) CA2269077C (da)
DE (2) DE69728415T2 (da)
DK (1) DK0935652T3 (da)
ES (1) ES2218666T3 (da)
GB (1) GB2322132B (da)
PT (1) PT935652E (da)
WO (1) WO1998016642A1 (da)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6693077B1 (en) 1995-02-14 2004-02-17 Human Genome Sciences, Inc. Keratinocyte growth factor-2
US6077692A (en) 1995-02-14 2000-06-20 Human Genome Sciences, Inc. Keratinocyte growth factor-2
US7232667B2 (en) 1995-02-14 2007-06-19 Human Genome Sciences, Inc. Keratinocyte growth factor-2 polynucleotides
CA2263143A1 (en) * 1996-08-13 1998-02-19 Human Genome Sciences, Inc. Keratinocyte growth factor-2 (kgf-2 or fibroblast growth factor-12, fgf-12)
EP1452205B1 (en) * 1996-10-15 2007-11-28 Amgen Inc. Uses of keratinocyte growth factor-2
EP1041996A4 (en) 1997-12-22 2003-05-14 Human Genome Sciences Inc KERATINOCYTE GROWTH FACTOR-2 FORMULATIONS
US6869927B1 (en) 1997-12-22 2005-03-22 Human Genome Sciences, Inc. Keratinocyte growth factor-2 formulations
US6372494B1 (en) 1999-05-14 2002-04-16 Advanced Tissue Sciences, Inc. Methods of making conditioned cell culture medium compositions
AU5593200A (en) * 1999-06-02 2000-12-18 Human Genome Sciences, Inc. Keratinocyte growth factor-2 formulations
NZ516897A (en) * 1999-07-02 2004-01-30 Human Genome Sciences Inc Polynucleotides and associated polypeptides for KGF-2 (also known as Fibroblast Growth Factor 12) to promote and accelerate internal and external wound healing
EP1404713A4 (en) * 2001-05-24 2004-09-22 Human Dna Technology Inc NEW KERATINOCYTE GROWTH FACTOR 2 ANALOG IN HAIR FOLLICULES
WO2002098365A2 (en) * 2001-06-07 2002-12-12 Skinmedica, Inc. Conditioned cell culture media and uses thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ266622A (en) * 1993-06-29 1997-10-24 Chiron Corp Keratinocyte growth factor fragment (kgf) with at least a 2-fold increase in mitogenic activity compared to a full length kgf; dna molecules, expression vectors, host cells, and conjugates
DE69521789T2 (de) * 1994-02-01 2002-04-25 The United States Of Amerika Represented By The Secretary, Department Of Health And Human Fusionierte proteine die antikörper-teile und nicht-antikörper-teile enthalten
SI0785950T1 (en) * 1994-10-13 2003-08-31 Amgen Inc. Keratinocyte growth factor analogs
EP0804479B1 (en) * 1994-10-13 2006-10-11 Amgen Inc., Method of treating diabetes mellitus using kgf
DK0815115T3 (da) * 1995-02-14 2003-09-15 Human Genome Sciences Inc Keratinocytvækstfaktor-2
CA2263143A1 (en) * 1996-08-13 1998-02-19 Human Genome Sciences, Inc. Keratinocyte growth factor-2 (kgf-2 or fibroblast growth factor-12, fgf-12)

Also Published As

Publication number Publication date
DE69728415T2 (de) 2004-08-12
DE19781038T1 (de) 1998-12-10
JP2001506975A (ja) 2001-05-29
GB9811279D0 (en) 1998-07-22
PT935652E (pt) 2004-07-30
CA2269077C (en) 2004-04-06
EP0935652A1 (en) 1999-08-18
AU727678C (en) 2005-05-12
WO1998016642A1 (en) 1998-04-23
AU727678B2 (en) 2000-12-21
DE69728415D1 (de) 2004-05-06
GB2322132B (en) 1999-09-22
HK1022714A1 (en) 2000-08-18
ATE263239T1 (de) 2004-04-15
GB2322132A (en) 1998-08-19
AU4757697A (en) 1998-05-11
EP0935652B1 (en) 2004-03-31
CA2269077A1 (en) 1998-04-23
JP2008283980A (ja) 2008-11-27
ES2218666T3 (es) 2004-11-16

Similar Documents

Publication Publication Date Title
PT101297A (pt) Factores mitogenicos gliais, sua preparacao e utilizacao
CY1107628T1 (el) Ανθρωπινα ctla-4 αντισωματα και χρησεις αυτων
ES2133813T3 (es) Cadenas de lamininas: diagnostico y uso terapeutico.
IL117425A0 (en) Receptor activation by gas6
WO1996034107A3 (en) Antiviral proteins, dna coding sequences therefor, and uses thereof
BG102071A (en) Minor molecule inhibitors of rotamase enzymic activity
MXPA02002384A (es) Polipeptidos similares al factor de crecimiento de fibroblastos.
DE69029657D1 (de) Menschliches cytokin, interleukin-9
DE68929043D1 (de) Für androgen-rezeptor-protein kodierende dna
IL143670A0 (en) Methods for the expression of active protein-immunoglobulin fusions, active protein-immunoglobulin fusions obtained thereby and pharmaceutical compositions containing the same
PT935652E (pt) Produtos de factor de crescimento de queratinocitos-2
BG101392A (en) Method of treating diabetes mellitus using kgf
HUP9902640A2 (hu) Gliasejtvonal-eredetű neurotróf faktor receptor
CY1109207T1 (el) Διαδικασια εχινοκανδινης
ES2110414T3 (es) Derivados de sacarina utiles como inhibidores de enzimas proteoliticas y su preparacion.
EP1141286A4 (en) Cytokine receptor chain
ATE331791T1 (de) Phosphodiesterase 10
HUT43106A (en) Dns sequences koding proteins of flesh-i type inhibitor activity and process for producing these proteins
DE69928395D1 (de) Cyclin-e2 proteine und dafür kodierende gene
WO1997008934A3 (en) Aryl acrylic acid derivatives useful as protein tyrosine phosphatase inhibitors
PT977859E (pt) O factor neurotrofico nnt-1
ATE376586T1 (de) Ppgpp-synthetase und expressionssysteme zur verbesserten herstellung von proteinen
ATE389014T1 (de) Phosphorylierte glyoxalase i und deren verwendung
DK143984A (da) Nitrogenkilde til organismer
NO971553L (no) Cytoplasmisk tyrosinkinase